ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

April 18, 2014

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

DCCP Funds 57 Percent Of Epidemiology R01a In FY 1981, Less In 1982 But Still Above The Average For All NCI

October 2, 1981